TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402).

José María Piulats et al.PubMed ↗Publisher ↗

No numbers read from the abstract.